معرفی
Jeremy Kortmansky, MD is an Associate Professor of Medicine (Medical Oncology) at Yale School of Medicine and Chief Network Officer of Smilow Cancer Hospital Network. He specializes in gastrointestinal oncology, focusing on colorectal and pancreatic cancers. His clinical roles include Associate Chief Medical Officer and Clinical Director of GI Medical Oncology at Yale Cancer Center.
Education:
- M.D., Northwestern University Medical School (1996)
- Residency in Internal Medicine, Thomas Jefferson University Hospital (1999)
- Fellowship in Oncology, Memorial Sloan Kettering Cancer Center (2003)
Research Interests: Investigating novel therapies for gastrointestinal cancers, including targeted treatments (e.g., MET inhibitors), immunotherapy combinations, and perioperative chemotherapy protocols. Key areas include colorectal neoplasms, pancreatic malignancies, and hepatocellular carcinoma. Collaborates with multidisciplinary teams on clinical trials and guideline development.
Publications: Recent work emphasizes phase II trials for metastatic colorectal cancer therapies, perioperative FOLFIRINOX for pancreatic cancer, and ASCO guidelines for hepatocellular carcinoma treatment. His research bridges clinical innovation with patient-centered care strategies.
Leadership & Affiliations:
- Director of GI Medical Oncology at Yale Cancer Center
- Member of Hepatic Arterial Infusion (HAI) Program and HIPEC Program
- Collaborates with teams in Developmental Therapeutics and Surgical Oncology
